Lang Ho Lee

8PUBLICATIONS
98CO-AUTHORS
Medical infection agents (incl. prions)Molecular targetsProteins and peptidesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Hypersonic propulsion and hypersonic aerothermodynamics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Aug 14, 2026
Nuclear RSK1 mediates interferon-γ-induced proinflammatory activation in human primary macrophages and humanized mice.

|Apr 22, 2026
Targeting CRTC2 reverses STK11 mutant NSCLC tumor resistance to immunotherapy.

|Jun 09, 2025
Defining Non-small Cell Lung Cancer Tumor Microenvironment Changes at Primary and Acquired Immune Checkpoint Inhibitor Resistance Using Clinical and Real-World Data.

Lang Ho Lee, Xin Xu, Thanos Mourikis

|Oct 20, 2022
Proprotein Convertase Subtilisin/Kexin 9 (PCSK9) Promotes Macrophage Activation via LDL Receptor-Independent Mechanisms.

Shunsuke Katsuki, Prabhash K Jha, Adrien Lupieri

|Sep 21, 2022
Preclinical Characterization and Phase I Study of an Anti-HER2-TLR7 Immune-Stimulator Antibody Conjugate in Patients with HER2+ Malignancies.

Filip Janku, Sae-Won Han, Toshihiko Doi

|Feb 10, 2022
Second Heart Field-Derived Cells Contribute to Angiotensin II-Mediated Ascending Aortopathies.

Hisashi Sawada, Yuriko Katsumata, Hideyuki Higashi

Pageof 2

Frequent Collaborators

4 joint publications

Sasha A Singh

3 joint publications

Arda Halu

3 joint publications

Masanori Aikawa

3 joint publications

Elena Aikawa